Lista de obras - Elena Gonzalez-Rey - Dominio Público Uruguay

A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.

artículo científico publicado en 2006

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses

artículo científico publicado en 2008

Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

artículo científico publicado en 2012

Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells.

artículo científico publicado en 2007

Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels

artículo científico publicado en 2013

Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function

artículo científico publicado en 2017

Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

artículo científico publicado en 2007

Autophagy and neuropeptides at the crossroad for parasites: to survive or to die?

artículo científico publicado en 2009

Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles.

artículo científico publicado en 2009

Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia.

artículo científico publicado en 2006

Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

artículo científico publicado en 2006

Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

scholarly article by Mario Delgado et al published 27 March 2008 in Arthritis and Rheumatism

Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction

artículo científico publicado en 2016

Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants

artículo científico publicado en 2010

Guidelines for the use and interpretation of assays for monitoring autophagy

artículo científico publicado en 2012

Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

scientific article published on 01 January 2010

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

artículo científico publicado en 2009

Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation

artículo científico publicado en 2014

Impact of protozoan cell death on parasite-host interactions and pathogenesis ⬇️

artículo científico publicado el 2 de diciembre de 2010

In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.

artículo científico publicado en 2008

Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.

artículo científico publicado en 2009

Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

artículo científico publicado en 2010

LABCG2, a new ABC transporter implicated in phosphatidylserine exposure, is involved in the infectivity and pathogenicity of Leishmania

artículo científico publicado en 2013

LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi.

artículo científico publicado en 2001

Lulling immunity, pain, and stress to sleep with cortistatin.

artículo científico

Mesenchymal stem cells induce the ramification of microglia via the small RhoGTPases Cdc42 and Rac1.

artículo científico publicado en 2014

Neuropeptides as pleiotropic modulators of the immune response.

scientific article published on 07 July 2011

Neuropeptides as therapeutic approach to autoimmune diseases.

scientific article published on January 2010

Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death.

artículo científico publicado en 2008

Neuropeptides: keeping the balance between pathogen immunity and immune tolerance

artículo científico publicado en 2010

New enzymes as potential therapeutic targets for trypanosomiases and leishmaniasis.

artículo científico publicado en 2011

Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

artículo científico publicado en 2015

Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation

artículo científico publicado en 2013

Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice.

artículo científico publicado en 2006

Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens

artículo científico publicado en 2013

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

artículo científico publicado en 2006

The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses.

artículo científico publicado en 2016

Therapeutic action of ghrelin in a mouse model of colitis.

artículo científico publicado en 2006

Therapeutic application of mesenchymal stromal cells in murine models of inflammatory bowel disease

artículo científico publicado en 2014

Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.

artículo científico publicado en 2006

Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.

artículo científico publicado en 2013

Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders

artículo científico publicado en 2014

Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells

artículo científico publicado en 2007

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses

artículo científico publicado en 2006

Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.

artículo científico publicado en 2014

Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide

artículo científico publicado en 2006

Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

artículo científico publicado en 2007

Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages

artículo científico publicado en 2009

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

artículo científico publicado en 2009

Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders

artículo científico publicado en 2007

VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease

scientific article published on 01 July 2006

VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.

artículo científico publicado en 2004

Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis

artículo científico publicado en 2007

Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.

artículo científico publicado en 2005

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

scientific article published on 04 October 2005

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation

artículo científico publicado en 2006

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

artículo científico publicado en 2006

Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.

artículo científico publicado en 2006

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis

artículo científico publicado en 2006

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

artículo científico publicado en 2005

Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells

artículo científico publicado en 2007

Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels

artículo científico publicado en 2008

Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis

artículo científico publicado en 2006

Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.

artículo científico publicado en 2006

Lista de obras de Elena Gonzalez-Rey

A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses

Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells.

Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels

Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function

Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

Autophagy and neuropeptides at the crossroad for parasites: to survive or to die?

Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles.

Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia.

Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction

Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants

Guidelines for the use and interpretation of assays for monitoring autophagy

Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation

Impact of protozoan cell death on parasite-host interactions and pathogenesis ⬇️

In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.

Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.

Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

LABCG2, a new ABC transporter implicated in phosphatidylserine exposure, is involved in the infectivity and pathogenicity of Leishmania

LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi.

Lulling immunity, pain, and stress to sleep with cortistatin.

Mesenchymal stem cells induce the ramification of microglia via the small RhoGTPases Cdc42 and Rac1.

Neuropeptides as pleiotropic modulators of the immune response.

Neuropeptides as therapeutic approach to autoimmune diseases.

Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death.

Neuropeptides: keeping the balance between pathogen immunity and immune tolerance

New enzymes as potential therapeutic targets for trypanosomiases and leishmaniasis.

Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation

Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice.

Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses.

Therapeutic action of ghrelin in a mouse model of colitis.

Therapeutic application of mesenchymal stromal cells in murine models of inflammatory bowel disease

Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.

Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.

Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders

Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses

Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.

Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide

Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders

VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease

VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.

Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis

Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells

Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels

Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis

Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.